Delivery Order SPE2DB20D1004-SPE2DB23FF9V1

Award Date 5/31/23
Potential Completion Date 6/1/23
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The $2,458.64 firm-fixed-price contract has a completion date of March 9, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,602.25, is for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.04 firm fixed-price delivery order is for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The contract has an ultimate completion date of September 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This contract represents a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.56, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4 gram quantity. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, valued at $5,560.32, is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 19, 2024. AmerisourceBergen, through its Corporate Office Division, will supply this respiratory medication to support government healthcare programs. The...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,360.56 firm fixed-price contract is for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $2,059.21 firm fixed-price contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of August 2, 2024 and is not a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,736,111 units of Spiriva Respimat 1.25 mcg inhalational medication, with a ceiling value of $3,271.00. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalers. The $3,578.37 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that supports U.S. military healthcare. The contract has an ultimate completion date of September 14, 2022 and was awarded on September 13, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $1,295.08, is a firm fixed price delivery order for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF9V1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,095,220 units of Spiriva Respimat 1.25 mcg inhalation medication. The contract has a firm fixed price of $2,460.29 and a completion date of June 1, 2023.

AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:29 AM